| Serial Number | 97315301 |
| Word Mark | S |
| Filing Date | Wednesday, March 16, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 21, 2023 |
| Description of Mark | The mark consists of a stylized "S". |
| Goods and Services | Therapeutic products in the nature of pharmaceuticals to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical agents that modulate metabolism for scientific and research use |
| Pseudo Mark | SENDA |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Research and development in the field of computational biology, biotechnology and pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 16, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 19, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Senda Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02140 |
| Party Name | Senda Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02140 |
| Event Date | Event Description |
| Monday, January 9, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 22, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 27, 2022 | ASSIGNED TO EXAMINER |
| Monday, January 9, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, January 9, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, January 19, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 19, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 19, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 16, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, February 16, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, February 16, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, February 16, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, February 16, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 21, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 16, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, November 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, November 10, 2023 | SOU EXTENSION 1 FILED |
| Friday, November 10, 2023 | SOU EXTENSION 1 GRANTED |
| Monday, June 17, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, July 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Tuesday, November 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |